TG Therapeutics
TGTX
#3111
Rank
NZ$8.29 B
Marketcap
NZ$51.95
Share price
-0.76%
Change (1 day)
-30.17%
Change (1 year)

Earnings for TG Therapeutics (TGTX)

Earnings in 2025 (TTM): NZ$0.22 Billion

According to TG Therapeutics's latest financial reports the company's current earnings are NZ$0.61 Billion. , an increase over its 2024 earnings that were of NZ$85.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for TG Therapeutics from 1996 to 2025

Annual earnings

Year Earnings Change
2025 NZ$0.23 B169.57%
2024 NZ$85.53 M93.76%
2023 NZ$44.14 M-113.65%
2022 -NZ$0.33 Billion-45.06%
2021 -NZ$0.59 Billion25.42%
2020 -NZ$0.47 Billion62.93%
2019 -NZ$0.29 Billion-3.34%
2018 -NZ$0.3 Billion46.05%
2017 -NZ$0.21 Billion48.38%
2016 -NZ$0.14 Billion29.09%
2015 -NZ$0.11 Billion12.99%
2014 -NZ$94.3 Million180.92%
2013 -NZ$33.57 Million
2009 -NZ$3.05 Million-59.85%
2008 -NZ$7.59 Million
2006 -NZ$17.2 Million-48.34%
2005 -NZ$33.28 Million215.12%
2004 -NZ$10.57 Million29.1%
2003 -NZ$8.19 Million159.59%
2002 -NZ$3.16 Million
2000 -NZ$5.41 Million12.38%
1999 -NZ$4.82 Million7.69%
1998 -NZ$4.47 Million-49.02%
1997 -NZ$8.77 Million82.14%
1996 -NZ$4.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Alkermes
ALKS
NZ$0.52 B 126.46%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Dr. Reddy's Laboratories
RDY
NZ$1.50 B 551.19%๐Ÿ‡ฎ๐Ÿ‡ณ India